The Burden of Multiple Myeloma Attributable to High Body Mass Index in BRICS Countries and Projections to 2040: A Joinpoint Regression and Age‐Period‐Cohort Analysis Based on GBD 2023
Cancer Medicine · 2026-11 · 15 (11)
DOI: 10.1002/cam4.72515 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 18.11.2026. Verfasst von Ziwei Zhou und 6 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
Background
Obesity is a well‐established risk factor for multiple myeloma (MM), yet the burden attributable to high body mass index (BMI) in BRICS countries remains unclear. This study assessed temporal trends, regional variations, and future projections of this burden.
Methods
Data from the Global Burden of Disease (GBD) 2023 study were used to estimate the incidence, mortality, prevalence, and disability‐adjusted life years (DALYs) of MM attributable to high BMI during 1990–2023 across Brazil, Russia, India, China, and South Africa. Age–period–cohort modeling, joinpoint regression, decomposition analysis, and Bayesian age–period–cohort forecasting were applied to evaluate trends and project the burden through 2040.
Results
Globally, deaths and DALYs increased substantially during 1990–2023, while age‐standardized rates increased more modestly. Considerable heterogeneity was observed across BRICS countries. India showed the most rapid long‐term increase, China accounted for the largest absolute burden in 2023, and South Africa exhibited among the highest age‐standardized rates, whereas the Russian Federation showed a recent declining trend. Decomposition analysis indicated that population growth was the predominant contributor to the global increase, while epidemiological change represented the major contributor in China and India. Age–period–cohort analysis demonstrated that the burden was concentrated among older populations, with increasing risks observed in more recent periods and birth cohorts, particularly in countries undergoing rapid epidemiological transitions. BAPC projections suggested continued increases in the global burden and in most BRICS countries through 2040, whereas declining trends were projected for the Russian Federation. Sex‐specific analyses showed a consistently higher burden among men, although sex differences varied across regions.
Conclusions
The high BMI‐related MM burden in BRICS countries is rising, with distinct regional patterns driven by demographic expansion and changing risk profiles. Targeted obesity prevention, cancer surveillance, and equitable access to MM diagnosis and treatment may help mitigate the future MM burden.
Förderung
- Natural Science Foundation of Hebei Province
Zitieren
APA
Zhou, Z., Liu, X., Zhang, X., Wen, S., Hua, H., Song, Z., & Wang, F. (2026). The Burden of Multiple Myeloma Attributable to High Body Mass Index in BRICS Countries and Projections to 2040: A Joinpoint Regression and Age‐Period‐Cohort Analysis Based on GBD 2023. Cancer Medicine, 15(11). https://doi.org/10.1002/cam4.72515
Vancouver
Zhou Z, Liu X, Zhang X, Wen S, Hua H, Song Z, et al. The Burden of Multiple Myeloma Attributable to High Body Mass Index in BRICS Countries and Projections to 2040: A Joinpoint Regression and Age‐Period‐Cohort Analysis Based on GBD 2023. Cancer Medicine. 2026;15(11). doi:10.1002/cam4.72515
BibTeX
@article{Zhou2026,
author = {Zhou, Ziwei and Liu, Xuan and Zhang, Xuejun and Wen, Shupeng and Hua, Huan and Song, Zhengrong and Wang, Fuxu},
title = {The Burden of Multiple Myeloma Attributable to High Body Mass Index in BRICS Countries and Projections to 2040: A Joinpoint Regression and Age‐Period‐Cohort Analysis Based on GBD 2023},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {11},
doi = {10.1002/cam4.72515}
}
EUVIMED